Table 3.
Outcome | 4 months | 12 months | ||||||
---|---|---|---|---|---|---|---|---|
Continuous variables: Crude and adjustedb difference in change of outcome between study groups (change for counselor minus change for web)c | ||||||||
Crude | Adjusted | Crude | Adjusted | |||||
Mean (95% CI) | p | Mean (95% CI) | p | mean (95% CI) | p | mean (95% CI) | p | |
Framingham Risk Scored | −0.8 (−1.7 to 0.1) | 0.09 | −1.0 (−1.8 to −0.1) | 0.03 | −0.2 (−1.4 to 1.0) | 0.72 | −0.6 (−1.7 to 0.5) | 0.30 |
Components of the Framingham Risk Score | ||||||||
Systolic blood pressure, mmHg | −1.8 (−5.5 to 1.9) | 0.35 | −1.5 (−4.5 to 1.5) | 0.33 | −2.3 (−6.3 to 1.7) | 0.26 | −2.6 (−6.1 to 0.9) | 0.14 |
Total cholesterol, mg/dL, | −4.3 (−11.5 to 2.9) | 0.24 | −2.9 (−9.2 to 3.3) | 0.36 | −4.1 (−12.2 to 4.1) | 0.33 | −2.4 (−9.8 to 5.1) | 0.53 |
HDL-C, mg/dL | −0.4 (−1.8 to 0.9) | 0.54 | −0.4 (−1.7 – 1.0) | 0.58 | −1.7 (−3.3 to −0.2) | 0.03 | −1.5 (−3.0 to −0.0) | 0.05 |
Dietary Intake | ||||||||
Fat Quality Screener Scoree | 0.2 (−0.3 to 0.7) | 0.46 | 0.03 (−0.3 to 0.4) | 0.87 | 0.2 (−0.3 to 0.7) | 0.51 | 0.02 (−0.4 to 0.3) | 0.93 |
Fruit and Vegetable servings/d | 0.1 (−0.2 to 0.4) | 0.46 | 0.3 (0.0 to 0.5) | 0.05 | 0.02 (−0.3 to 0.3) | 0.91 | 0.1 (−0.1 to 0.4) | 0.31 |
Carotenoid Indexf | 0.4 (−2.9 to 3.7) | 0.43 | 0.2 (−2.6 to 3.1) | 0.47 | 1.9 (−1.6 to 5.4) | 0.20 | 2.3 (−0.9 to 5.6) | 0.12 |
Physical Activity | ||||||||
RESIDE questionnaire—total walk time (minutes per week) | 25.1 (−25.9 to 76.1) | 0.33 | 31.4 (−10.4 to 73.3) | 0.14 | −41.7 (−99.1 to 15.6) | 0.15 | −39.6 (−85.6 to 6.5) | 0.09 |
Pedometer, steps per day in prior week | 356 (−386 to 1099) | 0.34 | 339 (−376 to 1054) | 0.35 | 455 (−266 to 1176) | 0.21 | 592 (−100 to 1284) | 0.09 |
Other Outcomes | ||||||||
Diastolic blood pressure, mmHg | −0.6 (−2.7 to 1.5) | 0.59 | −1.4 (−3. to 0.5) | 0.14 | −0.8 (−3.0 to 1.3) | 0.44 | −1.6 (−3.4 to 0.3) | 0.10 |
LDL-C, mg/dL, | −3.3 (−9.5 to 2.9) | 0.30 | −2.1 (−7.6 to 3.4) | 0.46 | −2.9 (−9.8 to 4.0) | 0.40 | −1.0 (−7.4 to 5.3) | 0.75 |
Weight in kg | 0.5 (−0.2 to 1.3) | 0.13 | 0.6 (−0.1 to 1.3) | 0.10 | 0.6 (−0.4 to 1.6) | 0.27 | 0.8 (−0.2 to 1.8) | 0.13 |
HgbA1c (all participants) | −0.2 (−0.4 to −0.02) | 0.03 | −0.1 (−0.3 to 0.04) | 0.14 | −0.2 (−0.4 to −0.04) | 0.02 | −0.2 (−0.3 to 0.00) | 0.05 |
HgbA1c (those with diabetes) | −0.2 (−0.5 to 0.1) | 0.12 | −0.1 (−0.3 to 0.2) | 0.48 | −0.3 (−0.6 to 0.03) | 0.07 | −0.2 (−0.4 to 0.1) | 0.20 |
hsCRP | −0.2 (−2.1 to 1.6) | 0.82 | −0.1 (−1.0 to 0.7) | 0.73 | 1.0 (−1.4 to 3.4) | 0.40 | 0.9 (−0.9 to 2.7) | 0.33 |
QOL, SF−12 Mental composite | 0.8 (−0.6 to 2.1) | 0.28 | 0.3 (−0.9 to 1.4) | 0.62 | 0.1 (−1.3 to 1.6) | 0.84 | −0.5 (−1.5 to 0.6) | 0.38 |
QOL, SF−12 Physical composite | 0.7 (−1.1 to 2.6) | 0.44 | 1.1 (−0.6 to 2.8) | 0.20 | 0.0 (−2.2 to 2.1) | 0.97 | 0.8 (−1.2 to 2.7) | 0.44 |
Categorical variables--medication use: Crude difference in percentage at 4 and 12 month follow-up (percentage for counselor minus percentage for web) | ||||||||
mean (95% CI) | P | mean (95% CI) | P | |||||
smoking | −1% (−6% to 4%) | 0.69 | −2% (−8% to 4%) | 0.59 | ||||
Taking aspirin | 0% (−9% to 10%) | 0.95 | 4% (−7% to 14%) | 0..48 | ||||
Morisky questionnaire for medication adherence—high adherence | −6% (−18% to 7%) | 0.36 | 3% (−11% to 17%) | 0.68 | ||||
Taking blood pressure medication | 3% (−2% to 9%) | 0.22 | 6% (−.2% to 12%) | 0.06 | ||||
Taking cholesterol medication | 6% (−2% to 14%) | 0.16 | 6% (−3% to 15%) | 0.20 |
See Table 2 for the number of participants with followed data used to calculate the difference scores in this table.
Adjusted for baseline value of variable, age, sex, race (white vs. other), BMI, prescription drug plan, HDL-C, HgA1c, and study site
A negative difference score indicates the value of the outcome is lower in the counselor group.
Framingham risk scores calculated as percent chance of developing angina, myocardial infarction, or coronary heart disease death over a 10 year time frame for those who did not developed cardiovascular disease from baseline to follow-up.
A lower score indicates improved fat quality.
Carotenoid index, calculated as the sum of α-carotene, β-carotene, β-cryptoxanthin, and zeaxanthin. Data presented are for non-smokers. A higher index indicates greater fruit and vegetable consumption. Statistical tests performed on log transformed data.
Abbreviations: HCL-C, high density lipoprotein cholesterol; RESIDE, RESIDential Environment Project; LDL-C, low density lipoprotein Cholesterol; HgbA1c, hemoglobin A1c; hsCRP, high sensitivity C-reactive protein; QOL, quality of life.